Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2614241000168118 | Lignocaine (Pfizer) (lidocaine 20 mg / 1 g) gel (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
2614251000168116 | Lignocaine (Pfizer) 2% gel | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Lignocaine (Pfizer) 2% gel, 10 g | has TPUU | True | Lignocaine (Pfizer) 2% gel | Inferred relationship | Some | 1 |
Lignocaine (Pfizer) 2% gel, 10 g, syringe | has TPUU | True | Lignocaine (Pfizer) 2% gel | Inferred relationship | Some | 1 |
Lignocaine (Pfizer) 2% gel, 10 x 10 g | has TPUU | False | Lignocaine (Pfizer) 2% gel | Inferred relationship | Some | 2 |
Lignocaine (Pfizer) 2% gel, 10 x 10 g, syringes | has TPUU | False | Lignocaine (Pfizer) 2% gel | Inferred relationship | Some | 2 |
Lignocaine (Pfizer) 2% gel, 10 x 10 g, syringes | has TPUU | True | Lignocaine (Pfizer) 2% gel | Inferred relationship | Some | 1676569480 |
Lignocaine (Pfizer) 2% gel, 10 x 10 g | has TPUU | True | Lignocaine (Pfizer) 2% gel | Inferred relationship | Some | 1696142148 |
Reference Sets
Trade product unit of use reference set